Skip to Main Content
Contribute Try STAT+ Today

After a five-year effort, the National Institute of Health late last week released its final policy for managing and sharing publicly funded scientific data. But some critics say the approach falls short, because the language may still make it possible for researchers to withhold their data.

The new policy, which replaces one issued in 2003, reflects an ongoing push for transparency by academics and scientists who maintain that, without access to scientific data, research cannot be easily replicated. For this reason, they have argued a lack of information inhibits greater scientific understanding that can adversely affect research decisions and, eventually, treatments and health care costs.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.